ReimburseIQ
ReimburseIQ
Investor Overview

The intelligence layer for healthcare reimbursement strategy.

ReimburseIQ transforms federally mandated payer pricing data into automated negotiation intelligence for independent healthcare providers — turning reimbursement opacity into targets, leverage signals, and measurable revenue lift.

Request Early Access ← Back to Platform Overview
reimburseiq — ai recommendation engine · payer analysis · revenue intelligence
LIVE
ReimburseIQ full dashboard
213K
Private medical practices in the US
150K+
Small independent clinics
1M+
Practicing US physicians
$100M+
Platform ARR potential
The data advantage

Built on a federally mandated data infrastructure.

Where the data comes from

ReimburseIQ's benchmark layer is built on rates reported directly by health insurance companies under federal price transparency mandates — the No Surprises Act and CMS machine-readable file requirements. These are rates insurers are legally required to publish, giving us a legitimate, expanding, regulatory-backed data source that improves in coverage over time.

Current coverage includes large national PPO plans. HMO plans and a growing set of regional payers are coming soon. Data refreshes quarterly to ensure current market signals.

Why this is defensible

The raw machine-readable files are notoriously large, inconsistently formatted, and difficult to parse at scale. Our proprietary peer-reviewed methodology for transforming that raw data into clean, actionable benchmarks is the moat — not just access to the underlying source.

Each new customer strengthens the benchmark accuracy of the intelligence layer, improving recommendations and tightening spread analysis over time. The data advantage compounds with scale.

Pricing architecture

Land small. Expand fast.

Entry product drives proof-of-value quickly. Core SaaS converts on clear ROI. Enterprise and licensing become the long-term infrastructure play.

Entry Product
$499–$1,499 one-time
Clarity Report — high-converting wedge designed to prove value fast and accelerate subscription conversion.
  • Benchmark + payer spread summary
  • Negotiation readiness signal
  • ROI estimate + recommended next steps
  • Drives PRO subscription conversion
TEAM — Multi-Location
$899–$1,999 /month
Land at one site, expand across locations. Group-level intelligence and operator reporting.
  • Multi-site dashboards + rollups
  • Operator reporting automation
  • Expanded benchmarking cohort controls
  • Org-level monitoring + permissions
ENTERPRISE — Strategic Intelligence Layer
$25K–$150K+ /year custom

API integrations, custom data pipelines, advanced segmentation. For PE-backed clinic networks, RCM vendors, and device manufacturers.

Data Licensing
$50K–$500K+ /year

The long-term infrastructure play: ReimburseIQ as a reimbursement data layer for analytics platforms, RCM vendors, and healthcare AI systems.

Revenue projections

Conservative to platform-scale outcomes.

Projections assume blended ARPA across PRO/TEAM tiers, 15% Clarity Report to PRO conversion, and 45-day average sales cycle at lower tiers. Enterprise revenue begins Year 2–3.

Year Clinic Customers ARR Range Key Drivers
Year 1 250–600 $2M – $6M Clarity Reports → PRO; tight ICP; rapid onboarding
Year 2 1,500–2,800 $12M – $26M Inside sales scale + referral loops + early partner distribution
Year 3 4,000–7,000 $32M – $65M Group expansion + enterprise pilots + licensing wins
reimburseiq — arr growth trajectory · conservative vs. funding-accelerated
ReimburseIQ ARR growth chart
~$9M
Conservative ARR

~1,200 customers, primarily PRO conversions

$40–50M
Funding-Accelerated

~6,000 customers, high funnel volume + inside sales

$100M+
Platform Outcome

Enterprise networks + licensing as infrastructure layer

Growth engine

Automated acquisition → inside sales scale

Phase 1 — Validate (0–90 days)

Clarity Report funnel + conversion playbook. Repeatable onboarding templates. Tight vertical focus on independent clinics.

Phase 2 — Inside Sales Engine (6–18 months)

SDR team + dialed outbound sequences. Clinic list-building at scale. Demo-to-close system + fast activation.

Phase 3 — Partner Distribution (18–36 months)

RCM / billing partners + co-sell distribution. Group and network rollups. API + licensing revenue streams.

Why now

The market conditions are urgent.

Payer complexity is rising

Reimbursement rates grow more fragmented every year. Independent practices are increasingly outgunned in negotiations without modern intelligence tools.

Price transparency creates urgency

Federal transparency mandates are making payer data more available — creating both the data source and the awareness that better information is possible.

Consolidation pressure is real

Independent practices face acquisition pressure from large health systems. Protecting margins through reimbursement intelligence is an existential need, not a nice-to-have.

Ready to dig in?

Request a full diligence pack.

We'll send platform details, market analysis, and next steps based on your interest — investor, partner, or early access.

Request Early Access Contact Directly